Bayer Canada

Latest News
Health Canada approves additional indication for NUBEQA® (darolutamide) for the treatment of metastatic castration-sensitive prostate cancer (mCSPC) in combination with docetaxel
On World Contraception Day, Bayer reaffirms commitment
Canadian post-secondary students in agriculture and food secure $96K
Bayer makes $165,000 available to support rural-based charities
Bayer Canada Named one of Canada’s Most Admired™ Corporate Cultures

Advance Your Career